Glenview Capital Management, LLC

stated that they own a 17.8% stake in Tenet Healthcare Corp (NYSE:THC) in a Form 13D/A disclosure that was filed with the Securities and Exchange Commission (SEC) on Monday, January 22nd. The investor owns 17,942,624 shares of the stock valued at approximately $321,890,675. The reporting parties listed on the disclosure included Glenview Capital Management, LLC and Larry Robbins. The disclosure is available through the SEC website at this hyperlink.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. boosted its position in Tenet Healthcare by 3.1% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 551,255 shares of the company’s stock worth $8,358,000 after purchasing an additional 16,676 shares during the last quarter. BerganKDV Wealth Management LLC raised its stake in shares of Tenet Healthcare by 7.9% in the fourth quarter. BerganKDV Wealth Management LLC now owns 47,968 shares of the company’s stock worth $727,000 after buying an additional 3,523 shares during the period. Public Employees Retirement System of Ohio raised its stake in Tenet Healthcare by 86.7% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 34,465 shares of the company’s stock valued at $566,000 after purchasing an additional 16,000 shares during the period. Sterling Capital Management LLC bought a new stake in Tenet Healthcare during the 3rd quarter valued at approximately $227,000. Finally, Scoggin Management LP bought a new stake in Tenet Healthcare during the 3rd quarter valued at approximately $657,000.

THC has been the subject of a number of recent research reports. Royal Bank of Canada reiterated a “hold” rating and issued a $19.00 target price on shares of Tenet Healthcare in a report on Monday, September 25th. Zacks Investment Research lowered Tenet Healthcare from a “hold” rating to a “sell” rating in a research report on Saturday. SunTrust Banks set a $15.00 target price on Tenet Healthcare and gave the company a “hold” rating in a research report on Sunday, October 15th. Robert W. Baird reissued a “buy” rating and issued a $23.00 price target on shares of Tenet Healthcare in a research report on Thursday, September 28th. Finally, Credit Suisse Group assumed coverage on Tenet Healthcare in a research report on Thursday, November 2nd. They set a “neutral” rating and a $15.00 target price on the stock. Five research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. Tenet Healthcare has an average rating of “Hold” and an average target price of $18.50.

In related news, Director George Fredrick Smitherman sold 1,300 shares of the stock in a transaction that occurred on Monday, January 15th. The stock was sold at an average price of $38.50, for a total value of $50,050.00. 3.10% of the stock is currently owned by company insiders.

Shares of Tenet Healthcare Corp (THC) traded up $0.70 during trading on Monday, hitting $17.94. The company’s stock had a trading volume of 966,646 shares, compared to its average volume of 2,670,000. Tenet Healthcare Corp has a fifty-two week low of $12.25 and a fifty-two week high of $22.72. The firm has a market capitalization of $1,810.00, a PE ratio of -3.26, a P/E/G ratio of 3.36 and a beta of 1.17. The company has a quick ratio of 1.21, a current ratio of 1.28 and a debt-to-equity ratio of 21.21.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Friday, October 27th. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.21. Tenet Healthcare had a negative return on equity of 5.61% and a negative net margin of 2.85%. The business had revenue of $4.59 billion during the quarter, compared to analysts’ expectations of $4.73 billion. equities analysts forecast that Tenet Healthcare Corp will post 0.69 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at https://www.thecerbatgem.com/2018/01/22/17-8-stake-of-tenet-healthcare-corp-thc-owned-by-glenview-capital-management-llc.html.

Tenet Healthcare Profile

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.